Ironwood Pharmaceuticals Inc Stock Price. Everything You Need To Know About The Ironwood Pharmaceuticals Inc Stock! Ironwood Pharmaceuticals Inc Stock Price. Everything You Need To Know About The Ironwood Pharmaceuticals Inc Stock!


Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. The company is headquartered in Boston, Massachusetts and currently employs 219 full-time employees. The company went IPO on 2010-02-03. The company develops and commercializes GI product opportunities in areas of significant unmet need, leveraging its demonstrated expertise and capabilities in GI diseases. LINZESS (linaclotide), its commercial product, in a class of GI medicines called guanylate cyclase type C agonists (GC-C agonists) and is indicated for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C), or chronic idiopathic constipation (CIC). LINZESS is available to adult men and women suffering from IBS-C or CIC in the United States and Mexico, IBS-C or chronic constipation in Japan, and IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA to adult men and women suffering from IBS-C or CIC in Canada, and to adult men and women suffering from IBS-C in certain European countries.



Ironwood Pharmaceuticals Inc Stock Price. Everything You Need To Know About The Ironwood Pharmaceuticals Inc Stock! performance

  • Employees 219
  • Company HQ Boston
  • Website https://www.ironwoodpharma.com/
  • IRWD Asset Type Common Stock
  • IRWD Market Capitalization 1B
  • Earnings Per Share -6.78
  • Dividends Per Share None
  • Dividend Date None
  • Quarterly Earnings Growth -0.685

Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to expand your investment portfolio? Look no further than Ironwood Pharmaceuticals. As a content marketing expert at Zorion, I am here to guide you through the process of investing in this promising stock. Ironwood Pharmaceuticals is a renowned biotechnology company dedicated to developing innovative treatments for gastrointestinal diseases. With a well-established track record and a strong pipeline, this stock presents an incredible opportunity for investors seeking growth potentials. To invest in Ironwood Pharmaceuticals from Malaysia, Thailand, Indonesia, or Vietnam, follow these simple steps. First, open an account with Zorion, the pioneering investment platform offering access to real US stocks and Pre-IPO companies. Once your account is set up, navigate to the stock market section and search for Ironwood Pharmaceuticals. Review the investment insights and recommendations provided by Zorion’s expert team, enabling you to make informed decisions. Moreover, Zorion offers an array of resources and educational materials to enhance your investment knowledge. Explore articles, videos, and tutorials tailored to retail investors from Malaysia, Thailand, Indonesia, and Vietnam. Stay updated with market trends, analysis, and expert opinions to make the most out of your investment journey. Investing in Ironwood Pharmaceuticals opens doors to potential growth and financial opportunities. Leverage Zorion’s insights, recommendations, and educational resources to make your investment decisions a success. Start investing in Ironwood Pharmaceuticals from Malaysia, Thailand, Indonesia, or Vietnam today and secure your financial future with Zorion.


Want To Buy Ironwood Pharmaceuticals Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: